Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000304318 | SCV000338067 | benign | not specified | 2016-04-26 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000864846 | SCV001005710 | benign | Emery-Dreifuss muscular dystrophy 5, autosomal dominant | 2024-12-17 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000304318 | SCV001474874 | benign | not specified | 2024-07-30 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV004714632 | SCV005289165 | benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV003920092 | SCV004729461 | benign | SYNE2-related disorder | 2019-02-18 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |